NWAM LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Sell
12,940
-299
-2% -$41.9K 0.1% 191
2025
Q4
$1.8M Sell
13,239
-935
-7% -$114K 0.1% 192
2025
Q3
$1.72M Sell
14,174
-931
-6% -$106K 0.09% 206
2025
Q2
$1.69M Sell
15,105
-59
-0.4% -$6.28K 0.1% 198
2025
Q1
$1.7M Sell
15,164
-1,325
-8% -$137K 0.15% 141
2024
Q4
$1.52M Sell
16,489
-13
-0.1% -$1.17K 0.09% 205
2024
Q3
$1.38M Sell
16,502
-84
-0.5% -$6.41K 0.08% 217
2024
Q2
$1.14M Buy
16,586
+557
+3% +$37.2K 0.33% 53
2024
Q1
$1.06M Sell
16,029
-1,183
-7% -$91K 0.09% 212
2023
Q4
$1.39M Buy
17,212
+1,490
+9% +$116K 0.11% 181
2023
Q3
$1.18M Sell
15,722
-2,098
-12% -$161K 0.12% 169
2023
Q2
$1.37M Sell
17,820
-1,002
-5% -$79.9K 0.11% 180
2023
Q1
$1.56M Sell
18,822
-159
-0.8% -$13.2K 0.16% 134
2022
Q4
$1.63M Buy
18,981
+1,306
+7% +$103K 0.14% 156
2022
Q3
$1.09M Sell
17,675
-1,003
-5% -$63.2K 0.1% 188
2022
Q2
$1.16M Sell
18,678
-1,690
-8% -$105K 0.11% 184
2022
Q1
$1.21M Sell
20,368
-3,825
-16% -$245K 0.09% 206
2021
Q4
$1.76M Buy
24,193
+8,340
+53% +$574K 0.14% 165
2021
Q3
$1.11M Buy
15,853
+2,508
+19% +$176K 0.1% 208
2021
Q2
$919K Buy
13,345
+308
+2% +$20.6K 0.09% 218
2021
Q1
$843K Buy
13,037
+1,990
+18% +$128K 0.08% 227
2020
Q4
$644K Sell
11,047
-2,016
-15% -$122K 0.07% 235
2020
Q3
$825K Sell
13,063
-4,382
-25% -$304K 0.14% 138
2020
Q2
$1.34M Buy
17,445
+219
+1% +$16.8K 0.19% 119
2020
Q1
$1.29K Buy
17,226
+1,864
+12% +$129K 0.03% 130
2019
Q4
$998K Buy
15,362
+1,800
+13% +$117K 0.17% 122
2019
Q3
$860K Buy
13,562
+629
+5% +$41.1K 0.16% 135
2019
Q2
$874K Buy
12,933
+900
+7% +$59.2K 0.17% 123
2019
Q1
$782K Sell
12,033
-1,206
-9% -$80.2K 0.17% 135
2018
Q4
$828K Sell
13,239
-601
-4% -$42K 0.21% 114
2018
Q3
$1.07M Buy
13,840
+184
+1% +$13.9K 0.24% 90
2018
Q2
$967K Sell
13,656
-205
-1% -$14.5K 0.23% 99
2018
Q1
$1.04M Sell
13,861
-353
-2% -$28.1K 0.26% 87
2017
Q4
$1.02M Sell
14,214
-2,283
-14% -$173K 0.26% 99
2017
Q3
$1.34M Buy
16,497
+3,477
+27% +$266K 0.35% 72
2017
Q2
$922K Buy
13,020
+616
+5% +$41K 0.16% 96
2017
Q1
$842K Buy
12,404
+1,084
+10% +$76.2K 0.26% 94
2016
Q4
$811K Buy
11,320
+974
+9% +$72.4K 0.27% 94
2016
Q3
$819K Sell
10,346
-109
-1% -$8.85K 0.06% 95
2016
Q2
$872K Sell
10,455
-1,660
-14% -$147K 0.34% 77
2016
Q1
$1.11M Sell
12,115
-386
-3% -$34.8K 0.44% 57
2015
Q4
$1.26M Buy
12,501
+501
+4% +$52.1K 0.52% 49
2015
Q3
$1.2M Buy
12,000
+1,000
+9% +$111K 0.99% 24
2015
Q2
$1.33M Sell
11,000
-104
-0.9% -$11.4K 0.56% 41
2015
Q1
$1.09M Buy
11,104
+2,654
+31% +$269K 0.47% 51
2014
Q4
$796K Buy
8,450
+2,227
+36% +$230K 0.35% 76
2014
Q3
$662K Sell
6,223
-152
-2% -$14.9K 0.24% 107
2014
Q2
$529K Buy
6,375
+1,012
+19% +$78.8K 0.16% 137
2014
Q1
$380K Buy
+5,363
New +$421K 0.13% 156
2013
Q4
Sell
-3,494
Closed -$220K 190
2013
Q3
$220K Sell
3,494
-791
-18% -$47.3K 0.11% 164
2013
Q2
$220K Buy
+4,285
New +$223K 0.11% 161

Other funds holding GILD

NWAM LLC's GILD Position: Q1 2026 in Review

NWAM LLC reduced its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, selling an estimated $41.9K and leaving 12,940 shares worth $1.8M. The position accounts for 0.1% of the portfolio, ranked #191.

NWAM LLC first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • NWAM LLC held 12,940 shares of Gilead Sciences worth $1.8M as of Q1 2026.
  • NWAM LLC sold 299 Gilead Sciences shares in Q1 2026, an estimated $41.9K.
  • Gilead Sciences made up 0.1% of NWAM LLC's portfolio in Q1 2026, its #191 holding.
  • NWAM LLC first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.